Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

[Diffuse primary fat replacement of the pancreas: an unusual cause of steatorrhea].

Aubert A, Gornet JM, Hammel P, Lévy P, O'Toole D, Ruszniewski P, Modigliani R, Lémann M.

Gastroenterol Clin Biol. 2007 Mar;31(3):303-6. French.

2.

Leukocyte scintigraphy compared to intraoperative small bowel enteroscopy and laparotomy findings in Crohn's disease.

Almer S, Granerus G, Ström M, Olaison G, Bonnet J, Lémann M, Smedh K, Franzén L, Bertheau P, Cattan P, Rain JD, Modigliani R.

Inflamm Bowel Dis. 2007 Feb;13(2):164-74.

PMID:
17206712
3.

Clinical features of inflammatory bowel disease.

Allez M, Modigliani R.

Curr Opin Gastroenterol. 2000 Jul;16(4):329-36.

PMID:
17031097
4.

A simple biological score for predicting low risk of short-term relapse in Crohn's disease.

Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lémann M, Mary JY; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

Inflamm Bowel Dis. 2006 Jul;12(7):551-7.

PMID:
16804391
5.

A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.

Lémann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R, Bouhnik Y; Groupe D'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.

Gastroenterology. 2005 Jun;128(7):1812-8.

PMID:
15940616
6.

Crohn's disease over 20 years after diagnosis in a referral population.

Etienney I, Bouhnik Y, Gendre JP, Lémann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC.

Gastroenterol Clin Biol. 2004 Dec;28(12):1233-9.

7.

[Acute hyperalgic gastritis inaugurating disseminated varicella in an immunodepressed patient].

Treton X, Gornet JM, Hassani Z, Modigliani R, Lémann M.

Gastroenterol Clin Biol. 2003 Nov;27(11):1041-2. French. No abstract available.

8.

Corticosteroids for maintenance of remission in Crohn's disease.

Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO.

Cochrane Database Syst Rev. 2003;(4):CD000301. Review.

PMID:
14583917
9.

Hydrostatic balloon dilatation of Crohn's strictures.

Sabaté JM, Villarejo J, Bouhnik Y, Allez M, Gornet JM, Vahedi K, Modigliani R, Lémann M.

Aliment Pharmacol Ther. 2003 Aug 15;18(4):409-13.

10.

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study.

Gornet JM, Couve S, Hassani Z, Delchier JC, Marteau P, Cosnes J, Bouhnik Y, Dupas JL, Modigliani R, Taillard F, Lemann M.

Aliment Pharmacol Ther. 2003 Jul 15;18(2):175-81.

11.

Clustering of Crohn's disease within affected sibships.

Hugot JP, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S, Chamaillard M, Macry J, Thomas G, Victor JM; GETAID.

Eur J Hum Genet. 2003 Feb;11(2):179-84.

12.

CARD4/NOD1 is not involved in inflammatory bowel disease.

Zouali H, Lesage S, Merlin F, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M, Thomas G, Hugot JP; EPWG group; EPIMAD group.

Gut. 2003 Jan;52(1):71-4.

13.

An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.

Sabate JM, Villarejo J, Lemann M, Bonnet J, Allez M, Modigliani R.

Aliment Pharmacol Ther. 2002 Jun;16(6):1117-24.

14.

Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy.

Allez M, Lemann M, Bonnet J, Cattan P, Jian R, Modigliani R.

Am J Gastroenterol. 2002 Apr;97(4):947-53.

PMID:
12003431
15.

[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].

Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lémann M.

Gastroenterol Clin Biol. 2002 Jan;26(1):17-22. French.

16.

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group.

Am J Hum Genet. 2002 Apr;70(4):845-57. Epub 2002 Mar 1.

17.

Medical management of fulminant colitis.

Modigliani R.

Inflamm Bowel Dis. 2002 Mar;8(2):129-34; discussion 138-9. Review. No abstract available.

PMID:
11854611
18.

[Infliximab therapy for Crohn's disease anoperineal lesions].

Ouraghi A, Nieuviarts S, Mougenel JL, Allez M, Barthet M, Carbonnel F, Cosnes J, Gendre JP, Flourié B, Meurisse JJ, Quandalle P, Ernst O, Lemann M, Cortot A, Modigliani R, Colombel JF.

Gastroenterol Clin Biol. 2001 Nov;25(11):949-56. French.

19.

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF, Sutherland LR.

Gastroenterology. 2002 Feb;122(2):512-30. Review. No abstract available.

PMID:
11832465
20.

Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease.

Zouali H, Chamaillard M, Lesage S, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G, Hugot JP; GETAID.

Eur J Hum Genet. 2001 Oct;9(10):731-42.

21.

Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study.

Cuillerier E, Lémann M, Bouhnik Y, Allez M, Rambaud JC, Modigliani R.

Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1291-6.

PMID:
11692053
22.

Corticosteroids for maintaining remission of Crohn's disease.

Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO.

Cochrane Database Syst Rev. 2001;(3):CD000301. Review. Update in: Cochrane Database Syst Rev. 2003;(4):CD000301.

PMID:
11686956
23.

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G.

Nature. 2001 May 31;411(6837):599-603.

PMID:
11385576
24.

Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.

Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P; BMBF Competence Network "Inflammatory Bowel disease".

Int J Colorectal Dis. 2001 Feb;16(1):1-11; discussion 12-3.

PMID:
11317691
25.

Immunosuppressors for inflammatory bowel disease: how long is long enough?

Modigliani R.

Inflamm Bowel Dis. 2000 Aug;6(3):251-7; discussion 158.

PMID:
10961598
26.

Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method.

Patey-Mariaud De Serre N, Cellier C, Jabri B, Delabesse E, Verkarre V, Roche B, Lavergne A, Brière J, Mauvieux L, Leborgne M, Barbier JP, Modigliani R, Matuchansky C, MacIntyre E, Cerf-Bensussan N, Brousse N.

Histopathology. 2000 Jul;37(1):70-7.

PMID:
10931221
27.

Methotrexate in Crohn's disease: long-term efficacy and toxicity.

Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF.

Am J Gastroenterol. 2000 Jul;95(7):1730-4.

PMID:
10925976
28.

Recurrent cholestatic jaundice associated with generalized pustular psoriasis: evidence for a neutrophilic cholangitis.

Allez M, Roux ME, Bertheau P, Erlinger S, Degott C, Morel P, Modigliani R, Rybojad M.

J Hepatol. 2000 Jul;33(1):160-2.

PMID:
10905601
29.

[Corticoids in intestinal inflammatory diseases: use].

Modigliani R.

Gastroenterol Clin Biol. 1999 Jun;23(5 Pt 2):B169-77. Review. French. No abstract available.

PMID:
10897789
30.

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soulé JC, Modigliani R, Touze Y, Catala P, Libersa C, Broly F.

Gastroenterology. 2000 Jun;118(6):1025-30.

PMID:
10833476
31.

Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.

Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C.

Cochrane Database Syst Rev. 2000;(2):CD000545. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000545.

PMID:
10796557
32.

Corticosteroids for maintaining remission of Crohn's disease.

Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO.

Cochrane Database Syst Rev. 2000;(2):CD000301. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD000301.

PMID:
10796525
33.

Idiopathic giant oesophageal ulcer in an immunocompetent patient. The efficacy of thalidomide treatment.

Ollivier S, Bonnet J, Lemann M, Coffin JC, Modigliani R, Jian R, Bertheau P, Flejou JF.

Gut. 1999 Sep;45(3):463-4. No abstract available.

34.

[Pregnancy outcome in inflammatory bowel diseases].

Tennenbaum R, Marteau P, Elefant E, Rambaud JC, Modigliani R, Gendre JP, Cosnes J.

Gastroenterol Clin Biol. 1999 May;23(5):464-9. French.

35.

Granulocytic sarcoma of the jejunum: a rare cause of small bowel obstruction.

Corpechot C, Lémann M, Brocheriou I, Mariette X, Bonnet J, Daniel MT, Bertheau P, Lavergne A, Modigliani R.

Am J Gastroenterol. 1998 Dec;93(12):2586-8. Review.

PMID:
9860434
36.

[6-mercaptopurine levels and study of blood lymphocyte subsets during azathioprine treatment of Crohn's disease].

Cattan S, Lémann M, Thuillier F, Bengoufa D, Rabian C, Ngo Y, Bouhnik Y, Messing B, Rambaud JC, Modigliani R.

Gastroenterol Clin Biol. 1998 Feb;22(2):160-7. French.

37.

Which immunosuppressors do you use to treat Crohn's disease and ulcerative colitis? In which order of priority and how worried are you about toxicity?

Modigliani R.

Inflamm Bowel Dis. 1998 Aug;4(3):244-7; discussion 253-4. Review. No abstract available.

PMID:
9741030
38.

Abnormal intestinal intraepithelial lymphocytes in refractory sprue.

Cellier C, Patey N, Mauvieux L, Jabri B, Delabesse E, Cervoni JP, Burtin ML, Guy-Grand D, Bouhnik Y, Modigliani R, Barbier JP, Macintyre E, Brousse N, Cerf-Bensussan N.

Gastroenterology. 1998 Mar;114(3):471-81.

PMID:
9496937
39.

Drug therapy for ulcerative colitis during pregnancy.

Modigliani R.

Eur J Gastroenterol Hepatol. 1997 Sep;9(9):854-7. Review.

PMID:
9355782
40.

[Severe colitis in mucoviscidosis].

Fournet JC, Lavergne A, Lémann M, Silly C, Sorin M, Modigliani R, Lenoir G, Brousse N.

Gastroenterol Clin Biol. 1997;21(8-9):619-22. Review. French.

41.

Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody.

Canva-Delcambre V, Jacquot S, Robinet E, Lémann M, Drouet C, Labalette M, Dessaint JP, Bengoufa D, Rabian C, Modigliani R, Wijdenes J, Revillard JP, Colombel JF.

Aliment Pharmacol Ther. 1996 Oct;10(5):721-7.

PMID:
8899079
42.

Clinical characteristics of Crohn's disease in 72 families.

Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Bélaïche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A.

Gastroenterology. 1996 Sep;111(3):604-7.

PMID:
8780563
43.

Methotrexate for the treatment of refractory Crohn's disease.

Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R.

Aliment Pharmacol Ther. 1996 Jun;10(3):309-14.

PMID:
8791956
44.
45.

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soulé JC, Rothman N, Gendre JP, Malafosse M.

Eur J Gastroenterol Hepatol. 1996 Mar;8(3):229-33.

PMID:
8724022
46.

Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soulé JC, Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaïche J, Mary JY.

Gastroenterology. 1996 Mar;110(3):688-93.

PMID:
8608877
47.

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C, Modigliani R, Rambaud JC.

Lancet. 1996 Jan 27;347(8996):215-9.

PMID:
8551879
48.

Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.

Campieri M, Gilat T, Hanauer S, Korelitz B, Lauritsen K, Malchow H, Martin F, Miglioli M, Modigliani R, Present D, Schölmerich J, Sutherland L.

Inflamm Bowel Dis. 1996 Winter;2(4):265-7. No abstract available.

PMID:
23282593
49.

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R.

Gut. 1995 Dec;37(6):811-8.

50.

Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis.

Lémann M, Galian A, Rutgeerts P, Van Heuverzwijn R, Cortot A, Viteau JM, Elewaut A, Belaiche J, Froguel E, Modigliani R.

Aliment Pharmacol Ther. 1995 Oct;9(5):557-62.

PMID:
8580278

Supplemental Content

Loading ...
Support Center